Oppenheimer raised the firm’s price target on Carlisle to $355 from $345 and keeps an Outperform rating on the shares. The firm notes Carlisle reported Q4 20 adjusted EPS of $4.17, well ahead of its/consensus $3.47/$3.55 estimates on robust CCM outperformance and CWT margin upside. Given Carlisle’s prospects for 2024 core growth upside, favorable price/cost trends, and substantial dry powder, Oppenheimer sees notable upside vs. forward earnings and cash flow estimates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CSL: